137 related articles for article (PubMed ID: 1638587)
1. Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group.
Parish LC; Doyle CA; Durham SJ; Wilber RB
Clin Ther; 1992; 14(3):458-69. PubMed ID: 1638587
[TBL] [Abstract][Full Text] [Related]
2. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
Iravani A; Doyle CA; Durham SJ; Wilber RB
Clin Ther; 1992; 14(2):314-26. PubMed ID: 1611652
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cefaclor AF in the treatment of skin and skin-structure infections.
Schupbach CW; Olovich KG; Dere WH
Clin Ther; 1992; 14(3):470-9. PubMed ID: 1638588
[TBL] [Abstract][Full Text] [Related]
4. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
Wiseman LR; Benfield P
Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Nolen TM
Clin Infect Dis; 1992 Jun; 14 Suppl 2():S255-63; discussion S272. PubMed ID: 1617046
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of cefprozil and cefaclor in children with bacterial infections of skin and skin structures.
Faingezicht I; Bolaños HJ; Arias G; Guevara J; Ruiz M
Pediatr Infect Dis J; 1992 Nov; 11(11):976-8. PubMed ID: 1454446
[No Abstract] [Full Text] [Related]
7. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
McCarty JM
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):846-50. PubMed ID: 7889958
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
Montero L
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():125-31. PubMed ID: 8818853
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
McCarty JM; Renteria A
Clin Infect Dis; 1992 Jun; 14 Suppl 2():S224-30; discussion S231-2. PubMed ID: 1617042
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Ball P
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Nolen T
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):866-71. PubMed ID: 7889961
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
Iravani A
Antimicrob Agents Chemother; 1991 Sep; 35(9):1940-2. PubMed ID: 1952874
[TBL] [Abstract][Full Text] [Related]
14. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
Parish LC; Aten EM
Cutis; 1984 Dec; 34(6):567-70. PubMed ID: 6394217
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
Christenson JC; Gooch WM; Herrod JN; Swenson E
J Antimicrob Chemother; 1991 Oct; 28(4):581-6. PubMed ID: 1761453
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
Dillon HC; Gray BM; Ware JC
Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
[TBL] [Abstract][Full Text] [Related]
18. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis.
Christenson JC; Swenson E; Gooch WM; Herrod JN
Antimicrob Agents Chemother; 1991 Jun; 35(6):1127-30. PubMed ID: 1929253
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
Ballantyne FN
Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
